The objective of this study is to increase our understanding of the mechanism by which hormones which act via the adenylate cyclase-cAMP-dependent protein kinase system regulate cellular processes such as growth, differentiation, and hormone secretion. We propose to study the mechanism of cAMP-dependent protein kinase activation in intact cells stimulated with hormones and other agents which raise intracellular levels of cAMP. We have developed a novel method to measure the state of activation of each cAMP-dependent protein kinase isoenzyme. This technique measures the activity associated with immunoprecipitated regulatory subunits. Immunoprecipitation will be used to determine the activation profiles of cAMP-dependent protein kinases in cells stimulated with hormones which raise intracellular cAMP and in cells treated with hormones which inhibit a rise in cAMP such as somatostatin. Studies designed to characterize the mechanism of activation of protein kinases are also proposed. A reconstituted system composed of partially purified membranes which have a hormone-sensitive adenylate cyclase, purified cAMP-dependent protein kinase and cyclic nucleotide phosphodiesterase will be used to determine whether the rate of cAMP turnover affects the rate of protein phosphorylation. These studies will also enhance our understanding of the kinetics of protein kinase activation since the rate limiting step will be the generation of cAMP. Studies are also proposed to characterize the cAMP-dependent protein kinase isoenzymes in AtT20 mouse pituitary tumor cells. These cells contain protein kinase I, free RI subunits and the neural-specific protein kinase II. The studies are designed to: a) determine the reason for the presence of free RI subunits, b) measure the rate of synthesis and turnover of protein kinase isoenzymes and, c) establish mutant cells which are defective in cAMP-dependent protein kinase isoenzyme expression. We will attempt to correlate functional properties of the cAMP-dependent protein kinase isoenzymes with physiological response of the cell to hormonal stimulation (adrenocorticotropin release). These studies should enhance our understanding of the pathophysiology of certain metabolic diseases and of malignant cell growth and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK027736-07
Application #
3228465
Study Section
(SSS)
Project Start
1981-06-01
Project End
1988-05-31
Budget Start
1987-06-01
Budget End
1988-05-31
Support Year
7
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Singh, I S; Luo, Z; Kozlowski, M T et al. (1994) Association of USF and c-Myc with a helix-loop-helix-consensus motif in the core promoter of the murine type II beta regulatory subunit gene of cyclic adenosine 3', 5'-monophosphate-dependent protein kinase. Mol Endocrinol 8:1163-74
Macleod, J; Mei, X; Erlichman, J et al. (1994) Association of the regulatory subunit of a type II cAMP-dependent protein kinase and its binding proteins with the fibrous sheath of rat sperm flagellum. Eur J Biochem 225:107-14
Morrill, G A; Doi, K; Erlichman, J et al. (1993) Cyclic AMP binding to the amphibian oocyte plasma membrane: possible interrelationship between meiotic arrest and membrane fluidity. Biochim Biophys Acta 1158:146-54
Keryer, G; Luo, Z; Cavadore, J C et al. (1993) Phosphorylation of the regulatory subunit of type II beta cAMP-dependent protein kinase by cyclin B/p34cdc2 kinase impairs its binding to microtubule-associated protein 2. Proc Natl Acad Sci U S A 90:5418-22
Luo, Z; Singh, I S; Fujihira, T et al. (1992) Characterization of a minimal promoter element required for transcription of the mouse type II beta regulatory subunit (RII beta) of cAMP-dependent protein kinase. J Biol Chem 267:24738-47
Licameli, V; Mattiace, L A; Erlichman, J et al. (1992) Regional localization of the regulatory subunit (RII beta) of the type II cAMP-dependent protein kinase in human brain. Brain Res 578:61-8
Singh, I S; Luo, Z J; Eng, A et al. (1991) Molecular cloning and characterization of the promoter region of the mouse regulatory subunit RII beta of type II cAMP-dependent protein kinase. Biochem Biophys Res Commun 178:221-6
Luo, Z; Shafit-Zagardo, B; Erlichman, J (1990) Identification of the MAP2- and P75-binding domain in the regulatory subunit (RII beta) of type II cAMP-dependent protein kinase. Cloning and expression of the cDNA for bovine brain RII beta. J Biol Chem 265:21804-10
Rubino, H M; Dammerman, M; Shafit-Zagardo, B et al. (1989) Localization and characterization of the binding site for the regulatory subunit of type II cAMP-dependent protein kinase on MAP2. Neuron 3:631-8
Weiss, A; Erlichman, J (1988) In situ reassociation of the regulatory and catalytic subunits of 3',5'-cyclic adenosine monophosphate-dependent protein kinase isoenzymes in AtT20 cells. Mol Endocrinol 2:412-9